With the changes to the 2024 voluntary scheme for branded medicines pricing, how is your company preparing, and what could VPAG mean for existing commercial models, UK presence, and patient access? Share your thoughts in our survey.Â
With the changes to the 2024 voluntary scheme for branded medicines pricing, how is your company preparing, and what could VPAG mean for existing commercial models, UK presence, and patient access? Share your thoughts in our survey.Â